Note

Aspire Pharma initiated and funded this article but had no input into the content and were able to review in advance of publication for factual accuracy and compliance checks only.

Medicines Optimisation Centricity

Aspire Pharma initiated and funded a series of workshops run and facilitated by HSJ (previously Wilmington Healthcare). The workshops brought together key NHS and Pharmacy stakeholders to debate and discuss two themes:

Workshop Series One

Held in March 2023

This series explored the practicalities of medicine optimisation, sharing best practices to determine “the way forward” to ensuring optimal medicine optimisation.

To learn more about the finding of workshop series 1 and to read the ‘Medicines Optimisation Centricity: The way forward’ white paper, please click here.

This workshop explored whether medicines optimisation could be creating health inequalities/inequities. The roundtable offered a chance to reflect on medicines optimisation within the new integrated care landscape. It examined whether it truly achieves its intended goals, or if the current approach actually exacerbates inequalities and negatively impact specific groups within our population.

To learn more about the finding of workshop series 2 and to read the ‘Medicines Optimisation Centricity: Is it creating health inequalities?’ white paper, please click here.

MOC1010347G1_MAY2025